Encompass Begin Period Cash Flow from 2010 to 2025
| EHC Stock | USD 100.67 0.31 0.31% |
Begin Period Cash Flow | First Reported 1990-03-31 | Previous Quarter 182.1 M | Current Value 198.9 M | Quarterly Volatility 136.6 M |
Check Encompass Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Encompass Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 161.5 M, Interest Expense of 95.3 M or Total Revenue of 2.8 B, as well as many indicators such as Price To Sales Ratio of 2.49, Dividend Yield of 0.0065 or PTB Ratio of 4.69. Encompass financial statements analysis is a perfect complement when working with Encompass Health Valuation or Volatility modules.
Encompass | Begin Period Cash Flow |
Latest Encompass Health's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Encompass Health Corp over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Encompass Health's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Encompass Health's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Encompass Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 98,882,800 | |
| Geometric Mean | 78,526,200 | |
| Coefficient Of Variation | 71.82 | |
| Mean Deviation | 51,257,800 | |
| Median | 104,200,000 | |
| Standard Deviation | 71,014,046 | |
| Sample Variance | 5043T | |
| Range | 295.1M | |
| R-Value | 0.49 | |
| Mean Square Error | 4111.7T | |
| R-Squared | 0.24 | |
| Significance | 0.05 | |
| Slope | 7,292,459 | |
| Total Sum of Squares | 75644.9T |
Encompass Begin Period Cash Flow History
About Encompass Health Financial Statements
Encompass Health stakeholders use historical fundamental indicators, such as Encompass Health's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Encompass Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Encompass Health's assets and liabilities are reflected in the revenues and expenses on Encompass Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Encompass Health Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 104.2 M | 123 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Encompass Health Correlation against competitors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.369 | Dividend Share 0.64 | Earnings Share 4.47 | Revenue Per Share | Quarterly Revenue Growth 0.127 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.